ON 05
Alternative Names: cON-05; ON-05Latest Information Update: 18 Apr 2023
At a glance
- Originator OncoOne
- Class Antineoplastics; Bispecific antibodies; Drug conjugates; Immunoconjugates; Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 18 Apr 2023 Preclinical trials in Solid tumours in Austria (Parenteral) before April 2023
- 18 Apr 2023 Pharmacodynamics data from preclinical studies in Solid tumors released by OncoOne
- 14 Apr 2023 Pharmacodynamics data from preclinical studies in Solid tumors presented at the 114th Annual Meeting of the American Association for Cancer Research (AACR-2023)